• Türkçe
    • English
  • English 
    • Türkçe
    • English
  • Login
View Item 
  •   DSpace@Medipol
  • Fakülteler
  • Tıp Fakültesi
  • Makale Koleksiyonu
  • View Item
  •   DSpace@Medipol
  • Fakülteler
  • Tıp Fakültesi
  • Makale Koleksiyonu
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Are intervertebral disc tissue cells damaged when attempting to prevent thrombus formation using dabigatran, a new oral anticoagulant?

Thumbnail

View/Open

Tam Metin / Full Text (1.005Mb)

Access

info:eu-repo/semantics/openAccess

Date

2019

Author

Kaplan, Necati
Karaaslan, Numan
Yılmaz, İbrahim
Yaşar Şirin, Duygu
Akgün, Feride Sinem
Çalışkan, Tezcan
Şimşek, Abdullah Talha
Özbek, Hanefi

Metadata

Show full item record

Citation

Kaplan, N., Karaaslan, N., Yılmaz, İ., Yaşar Şirin, D., Akgün, F. S., Çalışkan, T. ... Özbek, H. (2019). Are intervertebral disc tissue cells damaged when attempting to prevent thrombus formation using dabigatran, a new oral anticoagulant? Turkish Neurosurgical, 29(4), 470-477. https://doi.org/10.5137/1019-5149.JTN.24336-18.0

Abstract

AIM: To investigate the effect of dabigatran, a new oral anticoagulant, on human primary cell cultures isolated from intact intervertebral disc tissue. MATERIAL and METHODS: Cell cultures were prepared from tissues obtained from six cases who had undergone surgery due to spinal trauma. Dabigatran, an active pharmacological agent, was applied to intact annulus fibrosus (AF)/nucleus pulposus (NP) primary cell cultures from the study group. After performing cell viability, toxicity, and proliferation tests on all cultures in the control and study groups, the surface morphologies of the samples were evaluated. Subsequently, chondroadherin (CHAD), cartilage oligomeric matrix protein (COMP), and matrix metalloproteinase (MMP)-13 and -19 expressions were measured via a real-time polymerase chain reaction (RT-PCR). Data were analyzed statistically. RESULTS: In the proliferation assays performed on the 20th day of the study, cells in the dabigatran-supplemented group were reported to have lost 46.37% more viability than those in the control group. Expressions of all genes examined except MMP-13 were evaluated in the control group by time, but in contrast to the control group results, COMP and MMP-19 gene expressions decreased in the dabigatran-treated group. No CHAD or MMP-13 expression was noted in these cultures. CONCLUSION: The potential for a systemically applied drug to accumulate in tissue and negatively affect surrounding tissues and microstructures must be emphasized.

WoS Q Kategorisi

Q4

xmlui.dri2xhtml.METS-1.0.item-scopusquality

Q3

Source

Turkish Neurosurgical

Volume

29

Issue

4

URI

https://doi.org/10.5137/1019-5149.JTN.24336-18.0
https://hdl.handle.net/20.500.12511/4527

Collections

  • Makale Koleksiyonu [3522]
  • PubMed İndeksli Yayınlar Koleksiyonu [3863]
  • Scopus İndeksli Yayınlar Koleksiyonu [5975]
  • TR-Dizin İndeksli Yayınlar Koleksiyonu [2170]
  • WoS İndeksli Yayınlar Koleksiyonu [6094]



DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 




| Guide | Contact |

DSpace@Medipol

by OpenAIRE
Advanced Search

sherpa/romeo

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsInstitution AuthorORCIDTitlesSubjectsTypeLanguageDepartmentCategoryWoS Q ValueScopus Q ValuePublisherAccess TypeThis CollectionBy Issue DateAuthorsInstitution AuthorORCIDTitlesSubjectsTypeLanguageDepartmentCategoryWoS Q ValueScopus Q ValuePublisherAccess Type

My Account

LoginRegister

DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 


|| Guide || Library || İstanbul Medipol University || OAI-PMH ||

Kütüphane ve Dokümantasyon Daire Başkanlığı, İstabul, Turkey
If you find any errors in content, please contact: [email protected]

Creative Commons License
DSpace@Medipol by İstanbul Medipol University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..

DSpace@Medipol:


DSpace 6.2

tarafından İdeal DSpace hizmetleri çerçevesinde özelleştirilerek kurulmuştur.